Startseite>>Signaling Pathways>> Endocrinology and Hormones>> Androgen Receptor>>Androst-4-ene-3,17-diol, dipropanoate, (3β,17β)- (Androst-4-ene-3β,17β-diol, dipropionate)

Androst-4-ene-3,17-diol, dipropanoate, (3β,17β)- (Androst-4-ene-3β,17β-diol, dipropionate)

Katalog-Nr.GC31254

Products are for research use only. Not for human use. We do not sell to patients.

Androst-4-ene-3,17-diol, dipropanoate, (3β,17β)- (Androst-4-ene-3β,17β-diol, dipropionate) Chemische Struktur

Cas No.: 56699-31-1

Größe Preis Lagerbestand
1mg Please Inquire Please Inquire
5mg Please Inquire Please Inquire
10mg Please Inquire Please Inquire
20mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Androst-4-ene-3,17-diol, dipropanoate, (3β,17β)- is the dipropanoate of 4-Androstenediol, a metabolite of testosterone.

The dipropionate of androst-4-ene-3β,17β-diol is highly effective in stimulating the seminal vesicles of the mouse and is more efficient for prolonged stimulation of this tissue than testosterone propionate. When administered orally or by subcutaneous injection, androst-4-ene-3α,17α-diol and androst-4-ene-3β,17β-diol are equal in androgenic potency to testosterone in the chick's comb test[1].

Bewertungen

Review for Androst-4-ene-3,17-diol, dipropanoate, (3β,17β)- (Androst-4-ene-3β,17β-diol, dipropionate)

Average Rating: 5 ★★★★★ (Based on Reviews and 36 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Androst-4-ene-3,17-diol, dipropanoate, (3β,17β)- (Androst-4-ene-3β,17β-diol, dipropionate)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.